Medicare utilization — DR. PADMAJA V MALLIDI (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 31,500 | 33 | $0 | $27,662 |
| J9271 | Injection, pembrolizumab, 1 mg | 20,600 | 29 | $0 | $886,787 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,155 | 24 | $0 | $40,249 |
| J0185 | Injection, aprepitant, 1 mg | 11,830 | 40 | $0 | $16,238 |
| J9025 | Injection, azacitidine, 1 mg | 6,480 | 12 | $0 | $2,310 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·